NCI study shows feasibility of cancer screening protocol for patients with Li-Fraumeni syndrome
In a new study from the National Cancer Institute (NCI), part of the National Institutes of Health, researchers found a higher than expected prevalence of cancer at baseline screening in individuals with Li-Fraumeni syndrome (LFS), a rare inherited disorder that leads to a higher risk of developing certain cancers. The research demonstrates the feasibility of a new, comprehensive cancer screening protocol for this high-risk population.
Part of a representative image of a whole body MRI of an LFS patient. Arrow denotes lesion found to be lung adenocarcinoma
This page was last updated on Friday, January 21, 2022